mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.1 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |